Rodney Gorham has successfully used a Synchron brain-computer interface implant for five years, a milestone for the company. The implant, called the Stentrode, allows him to control digital devices with his thoughts, providing critical assistance as he lives with ALS.
Synchron is preparing for a larger pivotal trial needed for regulatory approval, working with the FDA to define clinical endpoints. The technology relies on decoding algorithms to translate neural signals into actions, with Gorham's long-term feedback being instrumental in its development.
The main topics covered are: the milestone of long-term BCI use, the technical function of Synchron's Stentrode implant, the path to regulatory approval, and the role of user feedback in evolving the technology's capabilities.